Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 16, 2022
Patent Application Number
15943237
Date Filed
April 2, 2018
Patent Citations
Patent Citations Received
Patent Primary Examiner
The present invention generally relates to immunoconjugates, particularly immunoconjugates comprising a mutant interleukin-2 polypeptide and an antibody that binds to PD-1. In addition, the invention relates to polynucleotide molecules encoding the immunoconjugates, and vectors and host cells comprising such polynucleotide molecules. The invention further relates to methods for producing the mutant immunoconjugates, pharmaceutical compositions comprising the same, and uses thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.